JulieA.LemieuxMD

PubMed

• 13 citations
  Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast.
  Éric Poirier, Christine Desbiens, Brigitte Poirier, Dominique K. Boudreau, Simon Jacob, Julie Lemieux, Catherine Doyle, Caroline Diorio, Jean-Charles Hogue, Louise Pro...> ;Journal of Surgical Oncology. 2018 May 1
• 5 citations
  Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
  Daniela Furrer, Simon Jacob, Annick Michaud, Louise Provencher, Julie Lemieux, Caroline Diorio> ;Clinical Breast Cancer. 2017 Nov 1
• 9 citations
  Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast canc...
  Daniela Furrer, Julie Lemieux, Marc-André Côté, Louise Provencher, Christian Laflamme, Frédéric Barabé, Simon Jacob, Annick Michaud, Caroline Diorio> ;Breast. 2016 Dec 1
• 153 citations
  Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy
  Sean A. Virani, Susan Dent, Christine Brezden-Masley, Brian Clarke, Margot K. Davis, Davinder S. Jassal, Chris A. Johnson, Julie Lemieux, Ian Paterson, Igal A. Sebag, ...> ;The Canadian Journal of Cardiology. 2016 Jul 1
• 117 citations
  Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31
  Karen A. Gelmon, Frances M. Boyle, Bella Kaufman, David Huntsman, Alexey Manikhas, Angelo Di Leo, Miguel Martin, Lee S. Schwartzberg, Julie Lemieux, Samuel Aparicio, L...> ;Journal of Clinical Oncology. 2015 May 10
• 98 citations
  Effect of Metformin vs Placebo on Weight and Metabolic Factors in NCIC CTG MA.32
  Pamela J. Goodwin, Wendy R. Parulekar, Karen A. Gelmon, Lois E. Shepherd, Jennifer A. Ligibel, Dawn L. Hershman, Priya Rastogi, Ingrid A. Mayer, Timothy J. Hobday, Jul...> ;Journal of the National Cancer Institute. 2015 Mar 1
• 23 citations
  No effect of scalp cooling on survival among women with breast cancer
  Julie Lemieux, Louise Provencher, Linda Perron, Jacques Brisson, C. Amireault, Caty Blanchette, Elizabeth Maunsell> ;Breast Cancer Research and Treatment. 2015 Jan 1
• 55 citations
  Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendations
  J. Boulanger, J.N. Boursiquot, G. Cournoyer, Julie Lemieux, M.S. Masse, K. Almanric, Marie-Pascale Guay> ;Current Oncology. 2014 May 16
• 63 citations
  Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis
  Sylvie Bérubé, Julie Lemieux, Lynne Moore, Elizabeth Maunsell, Jacques Brisson> ;Breast Cancer Research. 2014 Apr 19
• 14 citations
  Adjuvant treatment for endometrial cancer: literature review and recommendations by the Comité de l'évolution des pratiques en oncologie (CEPO).
  Mélanie Morneau, William Foster, Marc Lalancette, Thu Van Nguyen-Huynh, Marie-Claude Renaud, Vanessa Samouëlian, Nathalie Letarte, Karine Almanric, Gino Boily, Philipp...> ;Gynecologic Oncology. 2013 Oct 1
• 52 citations
  Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.
  Julie Lemieux, Caroline Diorio, Marc-André Côté, Louise Provencher, Frédéric Barabé, Simon Jacob, Christine St-Pierre, Éric Demers, Rosemarie Tremblay-LeMay, Corinne N...> ;Anticancer Research. 2013 Jun 1
• 18 citations
  Aromatase inhibitors in obese breast cancer patients are not associated with increased plasma estradiol levels
  Caroline Diorio, Julie Lemieux, Louise Provencher, Jean-Charles Hogue, Éric Vachon> ;Breast Cancer Research and Treatment. 2012 Oct 6
• A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32).
  Parulekar W, Chen BE, Elliott C, Shepherd LE, Gelmon KA, Pritchard KI, Whelan TJ, Ligibel JA, Hershman DL, Mayer IA, Hobday TJ, Rastogi P, Lemieux J, Ganz PA, Stamboli...> ;J. Clin. Oncol.. 2011-05-20
• Phase III study of taxane chemotherapy with lapatinib or trastuzumab as first-line therapy for women with HER2/neu-positive metastatic breast cancer (BC) (NCIC Clinica...
  Parulekar W, Chapman JW, Aparicio S, Murray Y, Boyle FM, Di Leo A, Kaufman B, Levy C, Manikhas A, Martin M, Pritchard KI, Schwartzberg LS, Burnell MJ, Dent S, Ellard S...> ;J. Clin. Oncol.. 2011-05-20
• 21 citations
  Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up
  Julie Lemieux, Christine Desbiens, Jean-Charles Hogue> ;Breast Cancer Research and Treatment. 2011 Mar 24
• 87 citations
  Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)
  Julie Lemieux, Pamela J. Goodwin, Louise Bordeleau, Sophie Lauzier, Valérie Théberge> ;Journal of the National Cancer Institute. 2011 Feb 2
• 150 citations
  Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
  Pamela J. Goodwin, Vuk Stambolic, Julie Lemieux, Bingshu E. Chen, Wendy R. Parulekar, Karen A. Gelmon, Dawn L. Hershman, Timothy J. Hobday, Jennifer A. Ligibel, Ingrid...> ;Breast Cancer Research and Treatment. 2011 Feb 1
• 6 citations
  Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study.
  Julie Lemieux, C. Amireault, Stéphanie Camden, Jacqueline Poulin> ;Hematology. 2010 Dec 1
• 21 citations
  Optimizing the management of HER2-positive early breast cancer: the clinical reality
  S. Verma, S. M. Lavasani, John R. Mackey, Kathleen I. Pritchard, Mark Clemons, S. Dent, J. Latreille, Julie Lemieux, L. Provencher, S. Verma, Stephen Chia, B. Wang, D....> ;Current Oncology. 2010 Aug 1
• 7 citations
  The Role of Neoadjuvant HER2-Targeted Therapies in HER2 Overexpressing Breast Cancers
  Julie Lemieux, Mark Clemons, Louise Provencher, Susan Dent, Jean Latreille, John R. Mackey, Kathleen I. Pritchard, Daniel Rayson, S. Verma, S. Verma, B. Wang, Stephen ...> ;Current Oncology. 2009 Sep 1
• 24 citations
  The Role of HER2-targeted Therapies in Women with HER2-Overexpressing Metastatic Breast Cancer
  Susan Dent, S. Verma, Jean Latreille, Daniel Rayson, Mark Clemons, John R. Mackey, S. Verma, Julie Lemieux, Louise Provencher, Stephen Chia, B. Wang, Kathleen I. Pritc...> ;Current Oncology. 2009 Aug 1
• Evaluation of factors associated with recruitment in hematological clinical trials: A retrospective study.
  Amireault C, Camden S, Poulin J, Lemieux J> ;J. Clin. Oncol.. 2009-05-20
• Evaluation of the incidence and of risk factors associated with trastuzumab-associated cardiac toxicity in routine clinical practice.
  Lemieux J, Côté M, Provencher L, Simard I, St-Pierre C, Demers E> ;J. Clin. Oncol.. 2009-05-20
• 45 citations
  Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling.
  Julie Lemieux, C. Amireault, Louise Provencher, Elizabeth Maunsell> ;Breast Cancer Research and Treatment. 2009 Feb 25
• 36 citations
  Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical Trials
  Julie Lemieux, Pamela J. Goodwin, Kathleen I. Pritchard, Karen A. Gelmon, Louise Bordeleau, Thierry Duchesne, Stéphanie Camden, Caroline Speers> ;Journal of Clinical Oncology. 2008 Sep 20
• Join now to see all